How pTau 217 and NfL blood-based biomarkers are reshaping diagnosis in Alzheimer’s and neurodegenerative disease
See why accessible, pathology-informed testing is becoming increasingly important for earlier diagnosis, patient stratification, and more efficient neurological care
